Synchron Announces Enrollment of First Patient in U.S. Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralysis
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
Companies extend decade-long partnership to help customers across industries realize value faster from app and…
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
- Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for…
SUWON, South Korea--(BUSINESS WIRE)--#AlzheimersDisease--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research…
SINGAPORE - Media OutReach - 4 May 2022 - In an unprecedented move, Apple has…
Net Income Increases by $17.0 Million; Adjusted EBITDA Grows 18.4% in Q1 2022 Compared to…
Technology transfer includes DBI® Ultra die-to-wafer hybrid bonding know-how SAN JOSE, Calif. & YOKOHAMA, Japan--(BUSINESS…
CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite…